Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Remibrutinib in Real-world Clinical Practice — Stella

Home/Chronic Spontaneous Urticaria/Remibrutinib in Real-world Clinical Practice

View on ClinicalTrials.gov

Recruiting

Back to Chronic Spontaneous Urticaria trials

Remibrutinib in Real-world Clinical Practice

Trial locations(1 site)

United States

Cleaver Dermatology, Kirksville, Missouri

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~3,280 participants

Started

February 2026

Primary completion

October 2031

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.